Back
For best output, select "Paper Size" as "A4" and "Margin" as "0" or "None".
To save or print to PDF, please select Print Destination > Save as PDF, enable Background Graphics under "More Settings", then click "Save".
During the congress, E-Posters will be accessible to all participants on the congress website 24/7, as well as in the E-poster stations in the congress center.
Preparing your E-Poster
Please review the E-Poster format requirements carefully when preparing your E-Poster. Should your E-Poster not meet the mentioned requirements, it may not be displayed as described above.
E-Poster Submission Deadline
Please prepare and upload your E-Poster no later than March 14, 2026 11.59PM CET. After this date, you will no longer be able to prepare and upload your E-poster and it will not be displayed and accessible on the congress website.
Please follow the instructions below to input your abstract title.
Abstract titles should be brief and reflect the content of the abstract.
The association between kidney disease and cancer has long been recognized. Likewise, the increase in cases treated of cancer patients who have disorders such as acute kidney failure or chronic kidney disease, or conversely, of patients with kidney problems who have kidney cancer or other types of tumours, has grown to the point that they already account for a significant number, both in the outpatient consultations of nephrology specialists, and in interconsultations, in hospitalization. The growing number of older adults and the increasing prevalence of chronic diseases mean that more patients could benefit from palliative care now and in the future. Palliative care refers to a form of therapeutic action that mitigates the discomfort of a disease, but that does not achieve a cure.
Adult patients who attended at the palliative care unit in the period from January 2024 to March 2025, and who presented some degree of renal failure, with a total of 2163 patients. Patients younger than 18 years, patients in the emergency room, surgical, or those admitted for outpatient procedures were excluded from the study cohort. A prospective, cross-sectional periodic prevalence study of adult patients was conducted. With a simple random sampling, using the classical formula for finite populations. The estimated sample size was 350 patients.
The most frequent sex was female in 59.71% and the average age was 61 years. The Main Cancer Diagnosis was: Breast Cancer 72%, Prostate Cancer 44%, Colorectal Cancer 40%, Cervical Cancer 28%, Hepatobiliary 27%, Hematological Tumors 26%, Pulmonary 25%, Ovarian 12%, Head and Neck 11% , Digestive Tract 10%.
11.1% of the patients had kidney failure and a significant percentage (25%) of these patients required renal replacement therapy during palliative treatment. CKD was the most frequently kidney failure with 51% vs 49% Aki Patients.
Currently, the Palliative Care approach is initiated early, based on the needs of the patients rather than the prognosis, and has been extended to non-oncological diseases, whose advanced and terminal stages require this type of assistance. The shared care between general resources (Primary Care, Oncology, Internal Medicine, Nephrology...) and advanced Palliative Care resources allows care to be adapted to the level of complexity of the needs detected. This study revealed a high prevalence of patients in need of palliative care and with both acute and chronic renal failure, where the most frequent sex was female in 59.71% and the average age was 61 years, which is consistent with the data obtained in articles that document that the age at the time of cancer diagnosis is generally 66 years. As for the types of cancer that most went to palliative care and presented some degree of renal involvement, we have: Breast Cancer 72%, Prostate Cancer 44%, Colorectal Cancer 40%, Cervical Cancer 28%, Hepatobiliary 27%, Hematological Tumors 26%, Pulmonary 25%, Ovarian 12%, Head and Neck 11% , Digestive Tract 10%.
11.1% of the patients had kidney failure and a significant percentage (25%) of these patients required renal replacement therapy during palliative treatment.
